Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2018-05-01 20:00:36
Reporting Period:
Accepted Time:
2018-05-01 20:00:36
Original Submission Date:
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1509190 Aratana Therapeutics Inc. PETX () 4/A
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1352447 Steven Peter St C/o Aratana Therapeutics, Inc.
11400 Tomahawk Creek Parkway, Suite 340
Leawood KS 66211
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-04-30 11,513 $5.00 660,746 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. This Form 4/A has been filed solely to change the code reported in Column 4 of Table I of the Reporting Person's Form 4 filed on April 30, 2018, which had inadvertently noted an "A" instead of "D" to reflect a disposition of the Issuer's common stock, due to an administrative error.
  2. The sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on September 13, 2017.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.99 to $5.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.